In a report released yesterday, Jonathan Wolleben from JMP Securities reiterated a Buy rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR – Research Report), with a price target of $91.00.

A lot more money is entering the system with revenue sharing set to go online July 1. But we still live in a time where there is little structure. One day soon, such NFL prospects may opt out ...

Last month, Musk asked a federal court to stop OpenAI from moving to a for-profit business structure. In the last year, Musk has twice sued OpenAI in an effort to stop the startup from adopting a ...

I thought of it as an AI problem.” That difference remains. Waymo currently employs a hybrid system, which combines AI elements (which have been trained on labeled data), high-definition maps ...